Poolbeg Pharma has received a decision to grant a European [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for [...]

Quest Diagnostics has introduced a new blood-based test for measurable [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Heidelberg Pharma has reported further clinical activity from its Phase [...]

CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]